Trigen Holdings Overview
- Year Founded
-
1992
- Status
-
Out of Business
- Employees
-
6
- Latest Deal Type
-
Out of Business
Trigen Holdings General Information
Description
Developer of cardiovascular drugs focusing on biologics for use in antithrombotic therapy. The company executes programs from early discovery through to late-stage clinical development and commercialization, thus helping patients get better solutions.
Contact Information
Website
www.trigen.co.ukCorporate Office
- Fraunhoferstraße 9
- 82152 Martinsried
- Germany
Corporate Office
- Fraunhoferstraße 9
- 82152 Martinsried
- Germany
Trigen Holdings Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 17-Dec-2009 | Completed | Out of Business | |||
| 3. Later Stage VC | 12-Oct-2005 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 01-Jan-2002 | $10.3M | $10.3M | Completed | Startup | |
| 1. Angel (individual) | Completed | Startup |
Trigen Holdings Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Trigen Holdings Patents
Trigen Holdings Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-0603374-D0 | Compounds and their use | Inactive | 21-Feb-2006 | ||
| GB-0603376-D0 | Compounds and their use | Inactive | 21-Feb-2006 | ||
| GB-0603378-D0 | Compounds and their use | Inactive | 21-Feb-2006 | ||
| AU-2007217529-A1 | Heterocyclic compounds and their use in the treatment of cardiovascular disease | Inactive | 21-Feb-2006 | ||
| CA-2643012-A1 | Heterocyclic compounds and their use in the treatment of cardiovascular disease | Inactive | 21-Feb-2006 | A61K31/381 |
Trigen Holdings Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Trigen Holdings Acquisitions (1)
Trigen Holdings’s most recent deal was a Merger/Acquisition with ProCorde. The deal was made on 11-Apr-2005.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ProCorde | 11-Apr-2005 | Merger/Acquisition | Drug Discovery |
Trigen Holdings Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| ProCorde | Munich, Germany | 2000 |
Trigen Holdings FAQs
-
When was Trigen Holdings founded?
Trigen Holdings was founded in 1992.
-
Where is Trigen Holdings headquartered?
Trigen Holdings is headquartered in Martinsried, Germany.
-
What is the size of Trigen Holdings?
Trigen Holdings has 6 total employees.
-
What industry is Trigen Holdings in?
Trigen Holdings’s primary industry is Biotechnology.
-
Is Trigen Holdings a private or public company?
Trigen Holdings is a Private company.
-
What is Trigen Holdings’s current revenue?
The current revenue for Trigen Holdings is .
-
How much funding has Trigen Holdings raised over time?
Trigen Holdings has raised $42.3M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
